SWEET is a research programme developing and testing a support package called HT&Me, which aims to help women who are prescribed hormone therapy following a breast cancer diagnosis. It is hoped HT&Me will help improve adherence to hormone therapy and improve quality of life for women.

The SWEET Study is now in the follow-up stage.